CO2022011593A2 - Método de preparación de derivados de amina heterocíclica - Google Patents
Método de preparación de derivados de amina heterocíclicaInfo
- Publication number
- CO2022011593A2 CO2022011593A2 CONC2022/0011593A CO2022011593A CO2022011593A2 CO 2022011593 A2 CO2022011593 A2 CO 2022011593A2 CO 2022011593 A CO2022011593 A CO 2022011593A CO 2022011593 A2 CO2022011593 A2 CO 2022011593A2
- Authority
- CO
- Colombia
- Prior art keywords
- heterocyclic amine
- preparation
- amine derivatives
- amine derivative
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Método para preparar un derivado de amina heterocíclica, y el método de preparación según la presente divulgación tiene la ventaja de que puede prepararse un derivado de amina heterocíclica que tiene un contenido de impurezas reducido con un alto rendimiento.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20200023899 | 2020-02-26 | ||
KR1020210025655A KR102531088B1 (ko) | 2020-02-26 | 2021-02-25 | 헤테로사이클릭아민 유도체의 제조 방법 |
PCT/KR2021/002440 WO2021172922A1 (ko) | 2020-02-26 | 2021-02-26 | 헤테로사이클릭아민 유도체의 제조 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2022011593A2 true CO2022011593A2 (es) | 2022-08-30 |
Family
ID=77490106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2022/0011593A CO2022011593A2 (es) | 2020-02-26 | 2022-08-17 | Método de preparación de derivados de amina heterocíclica |
Country Status (9)
Country | Link |
---|---|
US (1) | US20230094404A1 (es) |
EP (1) | EP4112617A4 (es) |
JP (1) | JP7447291B2 (es) |
CN (1) | CN115151537B (es) |
BR (1) | BR112022016729A2 (es) |
CO (1) | CO2022011593A2 (es) |
JO (1) | JOP20220199A1 (es) |
MX (1) | MX2022010391A (es) |
WO (1) | WO2021172922A1 (es) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE318812T1 (de) | 2000-12-21 | 2006-03-15 | Bristol Myers Squibb Co | Thiazolyl-inhibitoren von tyrosinkinasen der tec- familie |
WO2005056785A2 (en) | 2003-12-05 | 2005-06-23 | Vertex Pharmaceuticals, Inc. | Crystal structure of interleukin-2 tyrosine kinase (itk) and binding pockets thereof |
WO2005066335A1 (en) | 2003-12-30 | 2005-07-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | Crystal structure of the interleukin-2-inducible cell kinase (itk) kinase domain |
EP2532235A1 (en) | 2006-09-22 | 2012-12-12 | Pharmacyclics, Inc. | Inhibitors of bruton's tyrosine kinase |
WO2012035055A1 (en) * | 2010-09-17 | 2012-03-22 | Glaxo Group Limited | Novel compounds |
WO2014036016A1 (en) | 2012-08-31 | 2014-03-06 | Principia Biopharma Inc. | Benzimidazole derivatives as itk inhibitors |
WO2014055934A2 (en) | 2012-10-04 | 2014-04-10 | University Of Utah Research Foundation | Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors |
WO2015061247A2 (en) | 2013-10-21 | 2015-04-30 | Merck Patent Gmbh | Heteroaryl compounds as btk inhibitors and uses thereof |
CN104628657A (zh) * | 2013-11-06 | 2015-05-20 | 韩冰 | 一类治疗缺血性脑损伤的化合物及其用途 |
EP3715346B1 (en) * | 2014-10-22 | 2024-01-03 | Dana-Farber Cancer Institute, Inc. | Thiazolyl-containing compounds for treating proliferative diseases |
KR102613433B1 (ko) * | 2017-10-11 | 2023-12-13 | 주식회사 대웅제약 | 신규한 페닐피리딘 유도체 및 이를 포함하는 약학 조성물 |
KR102328682B1 (ko) * | 2018-08-27 | 2021-11-18 | 주식회사 대웅제약 | 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물 |
-
2021
- 2021-02-26 JO JOP/2022/0199A patent/JOP20220199A1/ar unknown
- 2021-02-26 CN CN202180015867.2A patent/CN115151537B/zh active Active
- 2021-02-26 BR BR112022016729A patent/BR112022016729A2/pt unknown
- 2021-02-26 WO PCT/KR2021/002440 patent/WO2021172922A1/ko active Application Filing
- 2021-02-26 JP JP2022551582A patent/JP7447291B2/ja active Active
- 2021-02-26 EP EP21761001.3A patent/EP4112617A4/en active Pending
- 2021-02-26 US US17/799,774 patent/US20230094404A1/en active Pending
- 2021-02-26 MX MX2022010391A patent/MX2022010391A/es unknown
-
2022
- 2022-08-17 CO CONC2022/0011593A patent/CO2022011593A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
JOP20220199A1 (ar) | 2023-01-30 |
US20230094404A1 (en) | 2023-03-30 |
JP2023515197A (ja) | 2023-04-12 |
BR112022016729A2 (pt) | 2022-10-11 |
EP4112617A4 (en) | 2024-03-13 |
CN115151537B (zh) | 2024-09-06 |
JP7447291B2 (ja) | 2024-03-11 |
CN115151537A (zh) | 2022-10-04 |
EP4112617A1 (en) | 2023-01-04 |
WO2021172922A1 (ko) | 2021-09-02 |
MX2022010391A (es) | 2022-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112023019797A2 (pt) | Inibidor derivado heterocíclico e método de preparação do mesmo e aplicação do mesmo | |
MY182971A (en) | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol | |
CO2017012893A2 (es) | Composiciones farmacéuticas que comprenden péptidos neo-antígenos o una sal de los mismos y métodos para preparar las mismas | |
PH12019500493A1 (en) | Solvate form of (r)-2-amino-3-phenylpropyl carbamate | |
MX2016006200A (es) | Metodos para preparar inhibidores de la replicacion de virus de influenza. | |
ECSP19081847A (es) | Método para preparar intermedio de derivado de 4-metoxipirrol | |
CL2016002224A1 (es) | Método de obtención de un recubrimiento inorgánico para partículas a base de nitrato de amonio. | |
NI201200140A (es) | Hidrato del hidrocloruro de agomelatina y preparación de éste | |
UA116053C2 (uk) | Застосування похідних бензоімідазолу-проліну | |
BR112016005207A8 (pt) | métodos e sistema para tratamento de uma formação subterrânea | |
ECSP19081839A (es) | Método para preparar intermedio de derivado de 4-metoxipirrol | |
UA116697C2 (uk) | Композиція для запобігання зараженню видами роду mycoplasma | |
MY193458A (en) | Microorganism for producing a mycosporine-like amino acid and method for producing a mycosporine-like amino acid using the same | |
CO2022011593A2 (es) | Método de preparación de derivados de amina heterocíclica | |
BR112018013492A2 (pt) | composição de aditivo sequestrante de sulfeto de hidrogênio e seus métodos de uso | |
BR112015015798A2 (pt) | método para a preparação de um composto | |
BR112015024495A2 (pt) | método para o corte de couros | |
PH12016501704A1 (en) | Method for producing 2-acyliminopyridine derivative | |
BR112015031820A2 (pt) | composto, composição farmacêutica, intermediário, processo para a preparação de um composto e métodos | |
CA2911044C (fr) | Procede de stabilisation d'une composition contenant au moins un produit de deshydratation interne d'un sucre hydrogene, composition obtenue et ses utilisations | |
BR112022002815A2 (pt) | Método para preparar 2-(fenilimino)-3-alquil-1,3-tiazolidin- 4-onas | |
BR112015023088A2 (pt) | método para preparar um composto, e, composto | |
CO2024007673A2 (es) | Procedimiento para la preparación de derivados de (2r,3s)-2-(benzo[d]imidazolilpropil)piperidin-3-ol | |
NI201200141A (es) | Hidrato del hidrobromuro de agomelatina y preparación de éste | |
BR112022011988A2 (pt) | Processo para a preparação enzimática de um carboxilato de xilitol, carboxilato de xilitol e seu uso |